Dynavax should take a leaf from its vaccine maker peer, Novavax, and work to monetize its CpG1018 adjuvant. Learn more about ...
Shares of Novavax Inc. NVAX rose 1.96% to $8.60 Wednesday, on what proved to be an all-around positive trading session for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback